What we achieved in 2025, together
Date
Research news
Date
We are pleased to announce that a Parkinson's research project has been awarded the inaugural BenevolentAI Award. The project will use an artificial intelligence platform’s capabilities to reason, deduce and suggest entirely new treatments for Parkinson’s.
Date
An international team has developed a cutting-edge technique, enabling human brain tissue to be studied in 3D.
Date
New international research suggests that too much calcium inside brain cells may trigger a chain reaction that leads to Parkinson's.
Date
We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.
Date
A study, featured in the Daily Mail, suggests a link between certain types of flu and risk of Parkinson's.
Date
New figures from Parkinson's UK show that more than 12,000 Scots are now living with Parkinson's, and numbers are continuing to rise.
Date
Researchers in Japan have discovered that people with Parkinson's may have lower levels of caffeine in their blood after drinking tea and coffee.
Date
Research supported by Parkinson's UK has identified a medicine used to treat tapeworm infections which could lead to new treatments for people with Parkinson's.
Date
UK researchers publish further evidence highlighting the need to licence pimavanserin for hallucinations and delusions in Parkinson's.
Date
New research suggests that a type of asthma drug that activates a protein called beta-adrenoceptors, may decrease risk of Parkinson's.